087010

PEPTRON is a biotechnology company specializing in the design, development, and manufacturing of long-acting peptide therapeutics and antibody-based drugs. The company utilizes its proprietary SmartDepot technology, an ultrasonic spray-drying platform, to create sustained-release formulations that extend the half-life of active ingredients. Its business segments include the development of new drugs, the provision of custom peptide synthesis services for research and clinical trials, and contract development and manufacturing (CDMO) for pharmaceutical partners. Key pipeline products include PT320 for Parkinson's disease, PT105 for prostate cancer, PT403 for diabetes and obesity, and PAb001, an antibody-drug conjugate candidate targeting MUC1. PEPTRON also markets a pharmaceutical product containing hyaluronidase for the early suppression of edema in post-cesarean section patients. The company serves research institutions, pharmaceutical companies, and hospitals, with a focus on global markets through strategic licensing partnerships. Founded in 1997, PEPTRON operates a GMP-compliant manufacturing facility to support clinical trials and commercial production.

Summarised from the company's own disclosures, fiscal year ended Mar 2026

Industry Biotechnology Homepage peptron.co.kr
Sector Healthcare IR page peptron.co.kr
Tags
peptide therapeutics, long-acting drugs, drug delivery systems, antibody-drug conjugates, cdmo, custom peptide synthesis, neurology, oncology, endocrinology, gynecology, SmartDepot, PepGen, PT320, PT105, PT403, PAb001, PND3174, COZYCURE
Press page —

Metrics

Valuation  
Market cap ₩ 2.468T
Market cap (USD) $ 1.817B
P/E -119.99
PEG —
P/BV 19.06
P/S 411.33
P/OCF -121.86
P/FCF -83.63
Dividend yield —
Turnover / mcap —
Returns  
ROE -9.4%
ROI -9.7%
ROIC -11.2%
Profit margin -245.3%
Growth  
Revenue growing Yes
Profits growing Yes
Revenue up 3y No
Revenue up 5y No
Earnings growth 3y (net profit CAGR) —
Quality  
Profitable No
Margin expanding Yes
Buying back stock No
Diluting (TTM) No
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) —
Quality score -41.2%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013
Revenue 5.635B 3.152B 3.342B 5.814B 6.625B 3.121B 1.801B 3.862B 3.215B 3.131B 2.812B 2.484B 3.103B
Net profit -13.824B -22.034B -15.922B -15.063B -15.042B -18.382B -17.718B -3.726B -4.427B -3.191B -2.73B -3.046B -2.059B
Free cash flow -23.08B -13.775B -11.705B -13.245B -11.313B -16.648B -14.606B -14.316B -27.471B -5.515B -2.605B -3.465B -1.382B

Filed figures

Figure Dec 2016 Dec 2017 Dec 2018 Dec 2019 Dec 2020 Dec 2021 Dec 2022 Dec 2023 Dec 2024 Dec 2025
Balance sheet detail
Trade receivables (KRW) 274M 720M 40.1M 70.7M 412M 387M 371M 415M 331M 612M
↳ YoY growth +1,941.0% +163.0% -94.4% +76.4% +483.1% -6.0% -4.3% +11.8% -20.1% +84.6%
↳ 5y CAGR +23.4% +62.8% +98.4% +7.2% -12.4% +59.6% +36.2% +8.2%
Other receivables (KRW) 274M 180M 355M 868M 628M 669M 1.39B 860M 1.48B 1.4B
Borrowings, current (KRW) 0.00 — — — — — 9.05B 4.55B 990M 3.49B
Borrowings, non-current (KRW) 2B 2B — 3B 9.05B 6.05B — 4.5B 8.06B 5.56B
Bonds payable (KRW) — 0.00 — — — — — — — —
Lease liabilities (KRW) — — 0.00 41M 188M 107M 177M 84M 187M 472M
Cash and deposits (KRW) 3.54B 962M 1.8B 2.45B 68B 4.64B 5.04B 4.26B 1.05B 4.38B
Intangible assets (KRW) 1.24B 1.06B 954M 902M 647M 605M 675M 1.81B 2.84B 3.18B
Net debt (borrowings + leases - cash) (KRW) -1.54B 1.04B — 591M -58.7B 1.52B 4.19B 4.87B 8.19B 5.14B
Cash flow detail
Operating cash flow (KRW) -2.73B -5.63B -4.18B -9.6B -13.6B -10.6B -11.7B -11B -12.8B -20.6B
Purchases of property, plant and equipment (KRW) -2.78B -21.8B -10.1B -5.01B -3.1B -699M -1.52B -731M -1.01B -2.49B
Purchases of intangible assets (KRW) -200M -28.9M -47.8M -99.9M -73.1M -76.2M -191M -1.26B -1.16B -503M
Share buybacks (cash effect) (KRW) — — — — — — — -891M 0.00 0.00
Interest paid (cash effect) (KRW) -70.6M -60.6M -117M -126M -219M -254M -273M -379M -484M -324M
Income taxes paid (cash effect) (KRW) -17M -76.8M 45.3M -45.9M 83.1M -320M -42M 19.7M 14.4M -577M
Free cash flow (OCF - PPE - intangibles) (KRW) -5.71B -27.5B -14.4B -14.7B -16.7B -11.4B -13.4B -13B -14.9B -23.6B
Income detail
Total comprehensive income (KRW) -3.53B -4.26B -3.83B -17.2B -18.5B -15B -9.27B -16.1B -22.1B -14.6B
Reported Nov 14, 2017 Jul 31, 2018 Aug 13, 2021 Mar 30, 2020 Aug 13, 2021 Mar 20, 2024 Mar 20, 2024 Mar 20, 2024 Mar 18, 2026 Mar 18, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

분기보고서 (2026.09) Bull 0 Bear 0 Routine

Prompts

PEPTRON (ticker 087010), listed in South Korea.

ETFs Holding PEPTRON

ETF Weight in ETF Shares Market value As of
DFAE 0.01% 6,523 $ 475.577K Nov 12, 2026